Good afternoon :)
Place Order
Add to Watchlist

Mangalam Drugs and Organics Ltd

MANGALAM

Mangalam Drugs and Organics Ltd

MANGALAM
Health CarePharmaceuticals
SmallcapWith a market cap of ₹190 cr, stock is ranked 2,515
High RiskStock is 3.46x as volatile as Nifty
121.721.24% (+1.49)
121.721.24% (+1.49)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹190 cr, stock is ranked 2,515
High RiskStock is 3.46x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹190 cr, stock is ranked 2,515
High RiskStock is 3.46x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
20.251.40
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.766.590.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Mangalam Drugs and Organics Limited is engaged in the manufacturing of drugs, medicines and allied products. The Company also manufactures active pharma ingredients (API), intermediates and specialty chemicals.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Loading...

Financial YearFY 2024TTM
Total Revenue368.69356.26
Raw Materialssubtract235.41320.49
Power & Fuel Costsubtract28.50
Employee Costsubtract39.07
Selling & Administrative Expensessubtract13.08
Operating & Other expensessubtract35.14
Depreciation/Amortizationsubtract14.6515.34
Interest & Other Itemssubtract13.9214.68
Taxes & Other Itemssubtract-2.00-3.65
EPS-5.745.94
DPS0.000.00
Payout ratio0.000.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2016

Annual report

PDF

Investor Presentation

May 24PDF
FY 2017

Annual report

PDF

Investor Presentation

Aug 3PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Mangalam Drugs and Organics Ltd-20.961.40
Sun Pharmaceutical Industries Ltd45.106.440.75%
Cipla Ltd30.064.620.85%
Torrent Pharmaceuticals Ltd68.7216.600.83%

Price Comparison

Compare MANGALAM with any stock or ETF
Compare MANGALAM with any stock or ETF
MANGALAM
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding50.30%0.00%0.00%0.11%49.58%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.10%0.10%0.10%0.26%0.21%0.11%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividends

Dividends are the portion of earnings that a company distributes to all its shareholders every year

MANGALAM has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateDec 21, 2017

Interim
Interim | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Dec 21, 2017

News & Opinions
Spotlight
Mangalam Drugs and Organics Ltd leads gainers in 'B' group

Soma Textiles & Industries Ltd, Saraswati Saree Depot Ltd, Pudumjee Paper Products Ltd and Balaji Telefilms Ltd are among the other gainers in the BSE's 'B' group today, 29 November 2024.Mangalam Drugs and Organics Ltd surged 16.99% to Rs 125.3 at 12:02 IST. The stock was the biggest gainer in the BSE's 'B' group. On the BSE, 1.71 lakh shares were traded on the counter so far as against the average daily volumes of 2411 shares in the past one month. Soma Textiles & Industries Ltd spiked 16.18% to Rs 63.06. The stock was the second biggest gainer in 'B' group. On the BSE, 2.06 lakh shares were traded on the counter so far as against the average daily volumes of 27213 shares in the past one month. Saraswati Saree Depot Ltd soared 11.53% to Rs 141.75. The stock was the third biggest gainer in 'B' group. On the BSE, 73043 shares were traded on the counter so far as against the average daily volumes of 11982 shares in the past one month. Pudumjee Paper Products Ltd advanced 11.32% to Rs 157.4. The stock was the fourth biggest gainer in 'B' group. On the BSE, 3.15 lakh shares were traded on the counter so far as against the average daily volumes of 1.07 lakh shares in the past one month. Balaji Telefilms Ltd added 11.28% to Rs 71.3. The stock was the fifth biggest gainer in 'B' group. On the BSE, 1.72 lakh shares were traded on the counter so far as against the average daily volumes of 12588 shares in the past one month. Powered by Capital Market - Live

5 days agoCapital Market - Live
Earnings
Mangalam Drugs and Organics reports standalone net profit of Rs 2.69 crore in the September 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.69 crore in the quarter ended September 2024 as against net loss of Rs 3.56 crore during the previous quarter ended September 2023. Sales declined 1.99% to Rs 79.75 crore in the quarter ended September 2024 as against Rs 81.37 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales79.7581.37 -2 OPM %10.912.69 - PBDT5.17-1.02 LP PBT1.20-4.75 LP NP2.69-3.56 LP Powered by Capital Market - Live

2 weeks agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to table results

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Mangalam Drugs and Organics AGM scheduled

Mangalam Drugs and Organics announced that the 51th Annual General Meeting (AGM) of the company will be held on 26 September 2024.Powered by Capital Market - Live

2 months agoCapital Market - Live
Earnings
Mangalam Drugs and Organics reports standalone net profit of Rs 2.68 crore in the June 2024 quarter

Net profit of Mangalam Drugs and Organics reported to Rs 2.68 crore in the quarter ended June 2024 as against net loss of Rs 9.54 crore during the previous quarter ended June 2023. Sales declined 12.08% to Rs 76.49 crore in the quarter ended June 2024 as against Rs 87.00 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales76.4987.00 -12 OPM %10.69-4.00 - PBDT4.45-6.87 LP PBT0.58-10.29 LP NP2.68-9.54 LP Powered by Capital Market - Live

3 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to declare Quarterly Result

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live

Sandur Manganese & Iron Ores Ltd leads gainers in ‘B’ group

2 years agoBusiness Standard

Future Lifestyle Fashions Ltd leads losers in ‘B’ group

2 years agoBusiness Standard

NSE-BSE bulk deals: KBC Eco Fund keeps dumping NCC shares

2 years agoEconomic Times

Chamanlal Setia Exports Ltd leads losers in ‘B’ group

3 years agoBusiness Standard